Biospecia

MUCOADHESIVE DRUG DELIVERY SYSTEM: A PROMISING STRATEGY FOR ENHANCED BIOAVAILABILITY

Babitha Borugadda — 2026-05-05

Mucoadhesive drug delivery systems (MDDS) have gained considerable attention as an effective approach to address the shortcomings of conventional drug delivery methods, particularly issues such as poor oral bioavailability, rapid drug elimination, and the need for frequent dosing. By adhering to mucosal surfaces, these systems prolong the residence time of dosage forms at the site of absorption, leading to enhanced drug uptake and sustained as well as controlled release profiles. MDDS are formulated using natural or synthetic polymers that interact with mucosal tissues through physicochemical mechanisms including hydrogen bonding, electrostatic interactions, and polymer chain interpenetration.

INTEGRATED STRATEGIES FOR THE MANAGEMENT OF INSOMNIA

Paramesh Chakali — 2026-05-11

One of the most prevalent sleep problems in the world is insomnia.1 The number of patients seeking pharmacological treatment for insomnia is steadily rising due to its increased prevalence. Unwanted anticholinergic side effects have restricted the long-standing use of tricyclic antidepressants for insomnia. Clinical trials for the hypocretin/orexin antagonist MK4035 are now underway. The effectiveness of serotonin antagonists and inverse agonists in treating insomnia is being studied; however, more recent studies looking at different mechanisms of action indicate that drugs that affect the histaminergic, serotonergic, hypocretin/orexin, and possibly gamma-aminobutyric acid B systems may be useful in treating insomnia. The management of insomnia is the main topic of this systematic review. Insomnia's primary causes and risk factors are examined, such as well as the requirements for a proper diagnosis. The Creative Commons Attribution License governs the distribution of this open access article (https: Reviewing the operational definitions and treatment of persistent insomnia is the goal of this paper. The findings of a computerized search on Pub conducted between 1980 and January 2009 were summarized. Chronic insomnia can be managed in several ways. It must be defined and distinguished from other co-morbid mental illnesses before therapy may begin.

FROM RISK TO QUALITY: QUALITY RISK MANAGEMENT IN PHARMA

Merimma Chilaka — 2026-05-21

According to the International Council for Harmonization's (ICH) Q9 (R1) guideline, which goes into effect in May 2023, Quality Risk Management (QRM) offers a systematic and scientific method for controlling risks to the quality of pharmaceutical products at every stage of their lifetime. In order to increase uniformity within quality systems, the updated advice places a strong emphasis on risk-based decision-making, suitable formality levels, and the elimination of subjectivity. By helping pharmaceutical companies to recognize, evaluate, control, communicate, and analyse risks that might affect product safety, effectiveness, and compliance, QRM works closely with quality assurance. This study emphasizes the function of risk assessments in the production, distribution, and regulatory contexts of pharmaceuticals, showing how methodical assessment aids in avoiding quality failures and maximizing resource use. Numerous risk management techniques and instruments are covered, along with their usefulness, advantages, as well as restrictions. In order to improve proactive risk management, the study also examines implementation issues and new developments including digital technology, data analytics, and predictive methodologies.

FROM RISK TO QUALITY: QUALITY RISK MANAGEMENT IN PHARMA TARGETING CANCER THROUGH IMMUNE MODULATION

Krupa Varma Chinnampalli — 2026-05-23

Cancer immunotherapy has emerged as a powerful strategy for treating cancer by enhancing the body’s own immune system to recognize and eliminate tumor cells. Both experimental and clinically approved therapies are being developed to improve treatment outcomes and achieve long-term tumor control. Several factors influence the effectiveness of immunotherapy, including tumor heterogeneity, gut microbiota composition, genomic variations, and epigenetic modifications. Understanding these factors helps researchers design more precise and personalized treatment approaches. A major focus of current research is the study of molecular mechanisms behind immune evasion and therapeutic resistance. Noncoding RNAs and epigenetic alterations play significant roles in regulating immune responses and tumor progression, making them promising targets for innovative intervention strategies. Various immunotherapy platforms, such as immune checkpoint inhibitors and other immune-based technologies, are being investigated and implemented in clinical practice to improve patient outcomes.

EMERGING TRENDS IN ELECTROSPUN POLYMERIC NANOFIBERS FOR CLINICAL WOUND MANAGEMENT

Rachel Martha Host Dasi — 2026-05-26

Chronic and non-healing wounds remain a major global healthcare challenge due to rising infection rates, treatment costs, and the growing prevalence of conditions such as diabetes. Conventional wound dressings often fail to provide adequate antibacterial protection, controlled drug delivery, and support for tissue regeneration. Recent advancements in nanotechnology, particularly electrospinning, have enabled the development of nanofibrous scaffolds that closely mimic the extracellular matrix, promoting enhanced cell proliferation, vascularization, and faster tissue repair for effective wound management, offering improved healing outcomes, reduced scarring, and enhanced tissue engineering potential while addressing the evolving demands of modern healthcare systems.